参芪复脉汤联合西药治疗慢性心衰的疗效及对心功能的影响探讨

  • 打印
  • 收藏
收藏成功


打开文本图片集

【摘 要】目的:探究分析在慢性心衰患者中采取参芪复脉汤联合西药治疗的效果。方法:从2019年7月至2021年7月我院收治的慢性心衰患者中抽选70例作为主要研究对象,采用随机数字表法分为两组,实验组35例,接受参芪复脉汤联合西药治疗,对照组35例,接受常规西药治疗,对比两组患者临床治疗效果。结果:治疗前,两组患者LVEF、LVEDV等心功能指标差异无统计学意义(P>0.05);治疗后,实验组患者LVEF明显高于对照组,LVEDV明显低于对照组,差异具有统计学意义(P0.05);治疗后,实验组患者工作状况、社会心理功能、一般生活功能、病情、体力等生活质量评分明显高于对照组,差异具有统计学意义(P

【关键词】参芪复脉汤;西药;慢性心衰;心功能

Effect of Shenqi Fumai decoction combined with western medicine on chronic heart failure and its effect on cardiac function

XIE Xiaodong

Central health center of Tiechang Town, Zhen’an County, Shangluo, Shaanxi 711503, China

【Abstract】Objective: To explore and analyze the effect of Shenqi Fumai decoction combined with western medicine in patients with chronic heart failure. Methods: 70 patients with chronic heart failure treated in our hospital from July 2019 to July 2021 were selected as the main research objects. They were randomly divided into two groups. 35 patients in the experimental group were treated with Shenqi Fumai decoction combined with western medicine, and 35 patients in the control group were treated with conventional Western Medicine. The clinical therapeutic effects of the two groups were compared. Results: Before treatment, there was no significant difference in LVEF, LVEDV and other cardiac function indexes between the two groups(P>0.05). After treatment, LVEF in the experimental group was significantly higher than that in the control group, and LVEDV was significantly lower than that in the control group(P0.05). After treatment, the scores of quality of life in the experimental group were significantly higher than those in the control group(P

【Key?Words】Shenqi Fumai Decoction; Western medicine; Chronic heart failure; Cardiac function

慢性心衰是一种由于多种原因导致的心脏功能与结构病变,当患者出现慢性心衰之后,心脏功能会受到很大的影响,舒张压和收缩压指标都会出现异常,所以临床上针对慢性心衰的治疗中,改善患者心功能指标是非常重要的[1]。(剩余3138字)

目录
monitor